Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
494 results:

  • 1. Update on FDG-PET in pediatric lymphoma.
    Kurch L; Kluge R
    Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):58-69. PubMed ID: 38587361
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia.
    Kim J; Byun JM; Hong J; Koh Y; Shin DY; Kim TM; Yoon SS; Park H; Kim I
    Medicine (Baltimore); 2024 Feb; 103(7):e37100. PubMed ID: 38363899
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Optimal dosage of rituximab for children with Burkitt lymphoma.
    Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
    Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Novel CD19-KIRS2/Dap12-BB CAR-T treatment for 3 Patients with Relapsed and Refractory B-Cell Tumors].
    Ji SW; Hua T; Wang JJ; Shao LY; Chen ZH; Liu JY; Cheng H; Chen W; Sun C; Wang X; Xu KL; Cao J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1860-1865. PubMed ID: 38071073
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
    Ge T; Liu H; Wang ZH; Cao Y; Zhang YC; Huang L; Qian WB; Zhou XX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):825-831. PubMed ID: 38049334
    [No Abstract]    [Full Text] [Related]  

  • 6. Health Care Resource Utilization and Total Costs of Care for adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
    Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
    Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Bortezomib Is Effective in the treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe.
    Din RU; Jiao A; Qiu Y; Mohan AAM; Yuen KC; Wong HT; Wan TM; Wong PO; Sin CF
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834095
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metabolic/endocrine disorders in survivors of childhood-onset and cranial radiotherapy- treated ALL/NHL: a meta-analysis.
    Zhang D; Gu M
    Reprod Biol Endocrinol; 2023 Oct; 21(1):91. PubMed ID: 37794442
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
    Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
    Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Testicular dysfunction at diagnosis in children and teenagers with haematopoietic malignancies improves after initial chemotherapy.
    Lopez Dacal J; Prada S; Correa Brito L; Ropelato MG; Ballerini MG; Rodriguez ME; Gutiérrez ME; Soria M; Morán L; Ferraro C; Bedecarrás P; Drelichman G; Aversa L; Bergadá I; Rey RA; Grinspon RP
    Front Endocrinol (Lausanne); 2023; 14():1135467. PubMed ID: 37260445
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Late-onset Cognitive Impairment and Modifiable Risk Factors in adult Childhood Cancer Survivors.
    Phillips NS; Stratton KL; Williams AM; Ahles T; Ness KK; Cohen HJ; Edelstein K; Yasui Y; Oeffinger K; Chow EJ; Howell RM; Robison LL; Armstrong GT; Leisenring WM; Krull KR
    JAMA Netw Open; 2023 May; 6(5):e2316077. PubMed ID: 37256617
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies.
    Schorr C; Forindez J; Espinoza-Gutarra M; Mehta R; Grover N; Perna F
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176053
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCL.
    Amitai I; Roos K; Rashedi I; Jiang Y; Mangoff K; Klein G; Forward N; Stewart D; Laneuville P; Bence-Bruckler I; Mangel J; Tomlinson G; Berinstein NL
    Eur J Haematol; 2023 Aug; 111(2):191-200. PubMed ID: 37157906
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
    Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
    Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers.
    Chang WH; Neal RD; Forster MD; Lai AG
    Nat Commun; 2023 Mar; 14(1):1484. PubMed ID: 36932095
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers.
    Hofmann G; Zierk J; Sobik B; Wotschofsky Z; Sembill S; Krumbholz M; Metzler M; Karow A
    Sci Rep; 2023 Mar; 13(1):4022. PubMed ID: 36899075
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants.
    Wang S; Zhu Y; Qian X; Ding T; Yuan Y; Li Y; Wu H; Chen T
    Adv Clin Exp Med; 2023 Aug; 32(8):855-863. PubMed ID: 36881367
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Response-adapted omission of radiotherapy in children and adolescents with early-stage classical hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-phl-C1): a titration study.
    Mauz-Körholz C; Landman-Parker J; Fernández-Teijeiro A; Attarbaschi A; Balwierz W; Bartelt JM; Beishuizen A; Boudjemaa S; Cepelova M; Ceppi F; Claviez A; Daw S; Dieckmann K; Fosså A; Gattenlöhner S; Georgi T; Hjalgrim LL; Hraskova A; Karlén J; Kurch L; Leblanc T; Mann G; Montravers F; Pears J; Pelz T; Rajić V; Ramsay AD; Stoevesandt D; Uyttebroeck A; Vordermark D; Körholz D; Hasenclever D; Wallace WH; Kluge R
    Lancet Oncol; 2023 Mar; 24(3):252-261. PubMed ID: 36858722
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. hodgkin lymphoma in Children and Adolescents of Northern Greece: 25-Year Results and Long-term Follow-up.
    Kourti M; Papakonstantinou E; Papagianni A; Arsos G; Ioannidou M; Pantoleon A; Antari V; Palabougiouki M; Kouskouras K; Venizelos I; Κoletsa T; Cheva A; Anastasiou A; Totikidis G; Tragiannidis A; Galli-Tsinopoulou A; Hatzipantelis E
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):322-326. PubMed ID: 36716084
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
    Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
    [No Abstract]    [Full Text] [Related]  


    of 25.